RANI - ranitherapeutics.com Qarzning balans kapitallashuviga nisbati

Rani Therapeutics Holdings, Inc. (RANI) grafik logotipi

Rani Therapeutics (RANI) sanoat gigantlari bilan ittifoqlar tuzgan holda robo-kapsulalarda biologik preparatlarni ishlab chiqadi. Balans hisobotidagi moliyaviy leverajning dinamik tendentsiyasi ushbu ittifoqlarni aqlli tabletkalar yaratayotgan AQSh laboratoriyalari ishi bilan bog'laydi, bunda 0.09 joriy metrik ko'rsatkichni tashkil etadi. Kelgusidagi narx belgilash imkoniyati va litsenziyalash salohiyati bevosita innovatsion dori yetkazib berish tizimining klinik sinovlari natijalariga bog'liq.

RANI (Rani Therapeutics Holdings, Inc.) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 28.10.2026gacha

ranitherapeutics.com (RANI) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Rani Therapeutics Holdings, Inc.|RANI - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati RANI|RANI - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Rani Therapeutics|RANI - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati ranitherapeutics.com|RANI - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Rani Therapeutics|RANI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Rani Therapeutics Holdings, Inc.|RANI - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati RANI|RANI - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Rani Therapeutics
Kompaniyaning barcha koʻrsatkichlari tahlili:RANI Rani Therapeutics Inc
Rani Therapeutics Holdings, Inc. asosiy tovari

Aktivlarning qiyosiy tahlili kapitalga nisbatan qarz yuklamasini baholashni talab qiladi. Ushbu koeffitsient umumiy majburiyatlarni kompaniyaning balans qiymatiga qiyoslaydi, bunda 0.09 qiymati moliyaviy leverajning joriy darajasini aks ettiradi. Oral dori formulalarini yaratish bo'yicha strategik ittifoqlar Rani Therapeutics (RANI) kompaniyasiga tashqi qarzlar miqdorini minimallashtirish imkonini beradi. Moliyaviy qarzning balans kapitalizatsiyasiga nisbatdagi kamayishi biznesning yuqori barqarorligini tasdiqlaydi.

Rani Therapeutics raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati TNXP (tonixpharma.com)|Qarzning balans kapitallashuviga nisbati China SXT Pharmaceuticals, Inc.|Qarzning sof aktivlarga nisbati Eupraxia Pharmaceuticals, Inc. EPRX|BioHarvest - Balans kapitallashuviga qarzlar|EXOZ: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati oramed.com|Entera Bio (ENTX) - Qarzning balans qiymatiga nisbati|HYFT: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar ABVC BioPharma Inc. (ABVC)|Cumberland Pharma (CPIX) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Quantum BioPharma Corp QNTM|Qarzning balans qiymatiga nisbati FibroGen, Inc. (FGEN)|Qarzning balans kapitaliga nisbati telomirpharma.com TELO|Balans kapitallashuviga qarzlar Synergy CHC Corporation (SNYR)|RLYB - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar LEXX|PULM (Pulmatrix Corporation) - Balans qiymatiga qarzlar|PTHL - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Aptorum|Balans kapitallashuviga qarzlar LYRA|Balans kapitallashuviga qarzlar IBO (Impact BioMedical, Inc.)|TNF Pharmaceuticals, Inc. (TNFA) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati cbdMD Inc. YCBD|PRFX (PainReform Ltd.) - Balans kapitallashuviga qarzlar|Altamira Therapeutics (CYTO) - Balans qiymatiga qarzlar|LIPO: Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar OptiNose Inc|Pieris (PIRS) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Procaps Group Corp|PTPI (Petros Pharmaceuticals) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar qlsyy.net (QLI)|ACELYRIN - Balans kapitallashuviga qarzlar|TFF Pharmaceuticals Inc. - Qarzning balans qiymatiga nisbati